Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Current Deferred Tax Assets (2010 - 2015)

Harvard Bioscience (HBIO) reported Current Deferred Tax Assets of $42000.0 for Q4 2015, down 97.23% year-over-year from $1.5 million in Q4 2014, and down 98.36% on a QoQ basis from $2.6 million in Q3 2015.

Harvard Bioscience (HBIO) has 6 years of Current Deferred Tax Assets data on file, last reported at $42000.0 in Q4 2015.

  • Quarterly Current Deferred Tax Assets fell 97.23% year-over-year to $42000.0 in Q4 2015, while the trailing twelve-month figure through Dec 2015 was $42000.0 (down 97.23% YoY) and the FY2015 annual result came in at $42000.0, down 97.23% from the prior year.
  • Current Deferred Tax Assets slipped to $42000.0 in Q4 2015 per HBIO's latest filing, from $2.6 million in the prior quarter.
  • Across five years, Current Deferred Tax Assets topped out at $5.7 million in Q3 2011 and bottomed at $42000.0 in Q4 2015.
  • The 5-year median for Current Deferred Tax Assets is $1.6 million (2013), against an average of $2.5 million.
  • Peak annual rise in Current Deferred Tax Assets reached 68.8% in 2015, while the deepest fall reached 97.23% in 2015.
  • Tracing HBIO's Current Deferred Tax Assets over 5 years: stood at $3.9 million in 2011, then slumped by 60.26% to $1.6 million in 2012, then decreased by 0.39% to $1.5 million in 2013, then slipped by 2.07% to $1.5 million in 2014, then slumped by 97.23% to $42000.0 in 2015.
  • Per Business Quant, the three latest HBIO Current Deferred Tax Assets figures stand at $42000.0 (Q4 2015), $2.6 million (Q3 2015), and $2.6 million (Q2 2015).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Harvard Bioscience 25.38 Mn 18.29 Mn 12.24 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2015 42,000.00
Dec 31, 2015 42,000.00
Sep 30, 2015 2.56 Mn
Sep 30, 2015 2.56 Mn
Jun 30, 2015 2.61 Mn
Jun 30, 2015 2.61 Mn
Mar 31, 2015 1.86 Mn
Mar 31, 2015 1.86 Mn
Dec 31, 2014 1.52 Mn
Dec 31, 2014 1.52 Mn
Sep 30, 2014 1.55 Mn
Sep 30, 2014 1.55 Mn
Jun 30, 2014 1.55 Mn
Jun 30, 2014 1.55 Mn
Mar 31, 2014 1.55 Mn
Mar 31, 2014 1.55 Mn
Dec 31, 2013 1.55 Mn
Dec 31, 2013 1.55 Mn
Sep 30, 2013 1.56 Mn
Sep 30, 2013 1.56 Mn
Jun 30, 2013 1.55 Mn
Jun 30, 2013 1.55 Mn
Mar 31, 2013 1.55 Mn
Mar 31, 2013 1.55 Mn
Dec 31, 2012 1.55 Mn
Dec 31, 2012 1.55 Mn
Sep 30, 2012 3.89 Mn
Sep 30, 2012 3.89 Mn
Jun 30, 2012 3.93 Mn
Jun 30, 2012 3.93 Mn
Mar 31, 2012 3.91 Mn
Mar 31, 2012 3.91 Mn
Dec 31, 2011 3.91 Mn
Dec 31, 2011 3.91 Mn
Sep 30, 2011 5.75 Mn
Sep 30, 2011 5.75 Mn
Jun 30, 2011 5.22 Mn
Jun 30, 2011 5.22 Mn
Dec 31, 2010 5.44 Mn
Dec 31, 2010 5.44 Mn